10 Shattuck St, Boston MA 02115 | (617) 432-2136
| |
Copyright © 2020 President and Fellows of Harvard College. All rights reserved.
Qualitative research is used to explore and understand people's beliefs, experiences, attitudes, behaviour and interactions. It generates descriptive, non-numerical data. Qualitative research methods include:
Quantitative research is used to generate numerical data or data that can be converted into numbers. Study types that are used in the health and medical field include:
Please note that a research study does not have to be exclusively quantitative or qualitative. Many studies will use a combination of both types of research.
In the Dictionary of Statistics and Methodology , Mixed-Method Research is defined as:
"Inquiry that combines two or more methods. This particular term usually refers to mixing that crosses the quantitative-qualitative boundary. However, that boundary is not necessarily the most difficult one to cross. For example, mixing surveys and experiments (both quantitative methods) may require more effort for many researchers than combining surveys and focus groups (the first quantitative and the second qualitative)."
Mixed method research. (1999). In Vogt, P. W. (Ed.). Dictionary of statistics & methodology (2nd ed.).
Home » Research – Types, Methods and Examples
Table of Contents
Definition:
Research refers to the process of investigating a particular topic or question in order to discover new information , develop new insights, or confirm or refute existing knowledge. It involves a systematic and rigorous approach to collecting, analyzing, and interpreting data, and requires careful planning and attention to detail.
The history of research can be traced back to ancient times when early humans observed and experimented with the natural world around them. Over time, research evolved and became more systematic as people sought to better understand the world and solve problems.
In ancient civilizations such as those in Greece, Egypt, and China, scholars pursued knowledge through observation, experimentation, and the development of theories. They explored various fields, including medicine, astronomy, and mathematics.
During the Middle Ages, research was often conducted by religious scholars who sought to reconcile scientific discoveries with their faith. The Renaissance brought about a renewed interest in science and the scientific method, and the Enlightenment period marked a major shift towards empirical observation and experimentation as the primary means of acquiring knowledge.
The 19th and 20th centuries saw significant advancements in research, with the development of new scientific disciplines and fields such as psychology, sociology, and computer science. Advances in technology and communication also greatly facilitated research efforts.
Today, research is conducted in a wide range of fields and is a critical component of many industries, including healthcare, technology, and academia. The process of research continues to evolve as new methods and technologies emerge, but the fundamental principles of observation, experimentation, and hypothesis testing remain at its core.
Types of Research are as follows:
Data Analysis Methods in Research are as follows:
Research methodology refers to the overall approach and strategy used to conduct a research study. It involves the systematic planning, design, and execution of research to answer specific research questions or test hypotheses. The main components of research methodology include:
Research has a wide range of applications across various fields and industries. Some of the key applications of research include:
Research plays a crucial role in advancing human knowledge and understanding in various fields of study. It is the foundation upon which new discoveries, innovations, and technologies are built. Here are some of the key reasons why research is essential:
Research is typically used when seeking to answer questions or solve problems that require a systematic approach to gathering and analyzing information. Here are some examples of when research may be appropriate:
The following are some of the characteristics of research:
Research has several advantages, including:
Some Limitations of Research are as follows:
Researcher, Academic Writer, Web developer
COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Position Summary
The Department of Medicine (DoM) is seeking a Chief Administrative Research Officer (CARO) to lead the development of a high-quality and successful research enterprise. As a senior executive, the CARO oversees and supports the administration of DoM’s research portfolio, aligning with the department’s business plan to create effective technical solution teams (i.e., pre- and post-award cores). This role involves designing and implementing programs, methods, tools, platforms, practices, and other activities to support the department’s research enterprise and engaging with university administrators, faculty researchers, and collaborative partners in basic, applied, and advanced research.
Reporting to the Department Administrator/COO, the CARO will lead the Research Administration team and be financially responsible for the department’s overall research portfolio. The CARO will collaborate closely with departmental and division leadership, the grants management team, principal investigators, and other University and external stakeholders to ensure compliance with Department of Medicine, Columbia University, Federal, and sponsor-specific requirements.
Responsibilities
Minimum Qualifications
Preferred Qualifications
Other Requirements
Successful completion of applicable compliance and systems training requirements.
Equal Opportunity Employer / Disability / Veteran
Columbia University is committed to the hiring of qualified local residents.
Columbia university is dedicated to increasing diversity in its workforce, its student body, and its educational programs. achieving continued academic excellence and creating a vibrant university community require nothing less. in fulfilling its mission to advance diversity at the university, columbia seeks to hire, retain, and promote exceptionally talented individuals from diverse backgrounds. , share this job.
Thank you - we'll send an email shortly.
Other Recently Posted Jobs
Variable hours officer, esol instructor, secretary b.
Refer someone to this job
Wait! Before you go, are you interested in a career at Columbia University? Sign up here!
Thank you, for sharing your information. A member of our team will reach out to you soon!
This website uses cookies as well as similar tools and technologies to understand visitors' experiences. By continuing to use this website, you consent to Columbia University's usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice .
To enjoy additional benefits
CONNECT WITH US
The research will be conducted at universities in the united states, australia, and china. .
Published - August 21, 2024 11:34 am IST
Image used for representation only. | Photo Credit: Tanvi Manhas/Chennai
The story so far: The Type 1 Diabetes Grand Challenge, a partnership between the Steve Morgan Foundation, Diabetes UK and JDRF, on Monday, August 12, 2024, announced grants of over £2.7 million for new research in the development of next-generation insulins to manage type 1 diabetes. The funding will accelerate research of insulins that imitate how healthy pancreas work, the initiative said.
Type 1 diabetes is a chronic condition characterised by deficient insulin production and requires frequent insulin administration, mostly daily or sometimes even multiple times a day. Without insulin, glucose continues to build up in the bloodstream, causing high blood sugar levels. The insulin hormone helps regulate blood sugar by allowing glucose to enter cells to be used up for manufacturing energy.
The funding will be provided to six new international research projects focused on developing the next-generation, or novel, insulins. The research will be conducted at universities in the United States, Australia, and China.
“The funded six new research projects address major shortcomings in insulin therapy. Potentially minimising the risk of hypoglycaemia through an insulin-glucagon combination would ease one of the major concerns associated with insulin therapy today. Therefore, these research projects, if successful might do no less than heralding a new era in insulin therapy,” Tim Heise, Vice Chair of Novel Insulins Scientific Advisory Panel of the Type 1 Diabetes Grand Challenge, said.
According to the Type 1 Diabetes Grand Challenge, four of the newly-funded projects are related to glucose responsive insulins (GRIs), which can respond to changing blood glucose levels.
GRIs activate only when there is a certain amount of glucose in the bloodstream and become inactive when it drops below a stipulated point. This is expected to prevent both hyperglycaemia (high blood glucose) and hypoglycaemia (low blood glucose).
Another research project focuses on developing a short-acting insulin. Among the currently available insulins, there is a delay between the administration of the drug and its action on blood glucose – even with the fastest acting variants. This can cause a spike in blood glucose levels before insulin can lower it, thus endangering the person.
The last funded project focuses on combining insulin with glucagon.
Also read: ‘Insulin’ homoeopathic tablets under CDSCO lens
Glucagon is also secreted by pancreas, and it increases blood sugar levels to prevent it from dropping below a critical level. The project relies on the concept that having both insulin and glucagon in one formulation can stabilise blood sugar levels.
The four GRI projects are being researched at Monash University, Australia, Wayne State University, U.S., Jinhua Institute of Zhejiang University in China, and University of Notre Dame, U.S.
The Monash University project involves development of a second generation of nano sugar-insulin system, based on advanced nanotechnology. In the first-generation experiment of this insulin delivery system, insulin and a glucose-sensing molecule in tiny particles called nano sugars are injected under the skin. These nano sugars react to very small changes in blood glucose and release insulin only when glucose levels are outside a range, without any intervention from the patient. The aim of this experiment is to reduce the number of times people with type 1 have to inject insulin.
Researchers at the Wayne University are working to develop a “smart insulin” which can detect changes in blood glucose levels and respond by releasing the right amount of insulin at the right time. Chemical engineer Zhiqiang Cao’s team plans to develop a smarter insulin which is “more” sensitive to changing glucose levels, because some novel insulins are not as powerful as the currently available ones, resulting in higher doses to obtain a similar impact on blood glucose levels.
The third project, conducted by researchers at the Jinhua Institute of Zhejiang University in China, involves novel insulins that respond immediately to rising blood glucose levels. This novel insulin forms a reservoir of insulin under the skin once it is injected, and can therefore be used either daily or weekly. The experiment uses an insulin/polymer complex as the starting point and adds a safe glucose-sensing molecule to it. In the project, the team will improve the GRI and ensure all components work together effectively. The next step will be to make sure the GRI releases insulin properly from the reservoir, especially when blood glucose levels are high.
Researchers at the University of Notre Dame, U.S, developed a smart insulin delivery system that uses tiny particles called nanocomplexes, which contain insulin. These nanocomplexes can also be injected under the skin to create a reservoir to automatically release insulin if blood sugar rises. The project will be developed further and tested in pigs exposed to relevant real-life scenarios.
Scientists at the Stanford University, U.S. are working on developing and testing an ultrafast-acting insulin that’s only active when needed and could reduce the risk of blood glucose highs and lows in people with type 1 diabetes.
The current fast-acting insulins are a group of six molecules which need to be separated to form single insulin molecules to regulate blood sugar. Sometimes, even these single molecules cluster into pairs, hindering the blood sugar regulation. The new research will focus on designing an insulin molecule that doesn’t cluster so that it acts in the bloodstream quickly. The design is based on insulin molecules found in the venom from the cone snail, a type of underwater snail that uses insulin as a weapon.
A team of researchers at the Indiana University, U.S. will combine insulin and glucagon in their project, to prevent the highs and lows in blood glucose. The molecules has been tested in rats with type 1 diabetes and found that it can reduce the risk of hypoglycemia both at mealtimes and throughout the day. The experiment will also test the stability of the molecule and explore different ways to manufacture it.
health / Health Hub / health treatment / diabetes / medical research / The Hindu Explains
Terms & conditions | Institutional Subscriber
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
Eli Lilly, maker of the weight-loss drug Zepbound, released new data indicating that weekly injections of the drug reduced the risk of progression to Type 2 diabetes by 94% among adults with prediabetes and obesity, or who were overweight, compared to a placebo.
The data comes as new research found a nearly 19% increase in cases of Type 2 diabetes in the U.S. between 2012 and 2022.
Additionally, patients who had a weekly injection of 15 milligrams of the tirzepatide-based drug had an average reduction of 22.9% of their body weight. Those on a placebo lost about 2.1% of their body weight.
The findings come after over three years of study by the drug manufacturer. Previously, 72-week findings were published in the New England Journal of Medicine in 2022.
"Obesity is a chronic disease that puts nearly 900 million adults worldwide at an increased risk of other complications such as type 2 diabetes," said Dr. Jeff Emmick, senior vice president of product development at Eli Lilly. "Tirzepatide reduced the risk of developing type 2 diabetes by 94% and resulted in sustained weight loss over the three-year treatment period. These data reinforce the potential clinical benefits of long-term therapy for people living with obesity and pre-diabetes."
RELATED STORY | Amid rise in childhood diabetes, man describes how to 'thrive' with disease
Dr. Jayne Morgan, president of medical affairs at Hello Heart, said the new data was "very significant."
"They really were looking at whether or not they could prevent people from transitioning or progressing from prediabetes, meaning you don't yet have diabetes but your glucose or sugar levels are higher than normal but they don't meet the criteria for diabetes. So how do we prevent these people from progressing to diabetes?" she said. "They gave 1,032 people this medication over a period of three years and they were able to prevent the progression of diabetes by 94% in this group of people."
Eli Lilly acknowledged that a 17-week off-treatment follow-up showed that some participants had developed diabetes and gained some, but not all, of their weight back after stopping the injections. Morgan suggested that in order to reap the benefits of this medication, a person might need to remain on the drug indefinitely.
"As we continue next-gen medications moving towards perhaps oral formulations or pills, moving away from these injections, we are hopeful that perhaps we can see some of that ground be regained, but currently these would be lifetime maintenance medications just like taking insulin or taking your blood pressure medication, something that would be maintained for life," she said.
RELATED STORY | New research finds nearly 19% increase in cases of Type 2 diabetes over a decade
Eli Lilly says that Zepbound uses hormone receptors to help people who are considered obese or overweight lose weight and keep it off.
However, these weight-loss drugs do have side effects. Eli Lilly noted that Zepbound can potentially cause numerous adverse gastrointestinal reactions.
About Scripps News
About the university, research at cambridge.
Our research supports recommendations to limit the consumption of processed meat and unprocessed red meat to reduce type 2 diabetes cases in the population Nita Forouhi
The findings are published today in The Lancet Diabetes and Endocrinology .
Global meat production has increased rapidly in recent decades and meat consumption exceeds dietary guidelines in many countries. Earlier research indicated that higher intakes of processed meat and unprocessed red meat are associated with an elevated risk of type 2 diabetes, but the results have been variable and not conclusive.
Poultry such as chicken, turkey, or duck is often considered to be an alternative to processed meat or unprocessed red meat, but fewer studies have examined the association between poultry consumption and type 2 diabetes.
To determine the association between consumption of processed meat, unprocessed red meat and poultry and type 2 diabetes, a team led by researchers at the University of Cambridge used the global InterConnect project to analyse data from 31 study cohorts in 20 countries. Their extensive analysis took into account factors such as age, gender, health-related behaviours, energy intake and body mass index.
The researchers found that the habitual consumption of 50 grams of processed meat a day - equivalent to 2 slices of ham - is associated with a 15% higher risk of developing type 2 diabetes in the next 10 years. The consumption of 100 grams of unprocessed red meat a day - equivalent to a small steak - was associated with a 10% higher risk of type 2 diabetes.
Habitual consumption of 100 grams of poultry a day was associated with an 8% higher risk, but when further analyses were conducted to test the findings under different scenarios the association for poultry consumption became weaker, whereas the associations with type 2 diabetes for each of processed meat and unprocessed meat persisted.
Professor Nita Forouhi of the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge, and a senior author on the paper, said: “Our research provides the most comprehensive evidence to date of an association between eating processed meat and unprocessed red meat and a higher future risk of type 2 diabetes. It supports recommendations to limit the consumption of processed meat and unprocessed red meat to reduce type 2 diabetes cases in the population.
“While our findings provide more comprehensive evidence on the association between poultry consumption and type 2 diabetes than was previously available, the link remains uncertain and needs to be investigated further.”
InterConnect uses an approach that allows researchers to analyse individual participant data from diverse studies, rather than being limited to published results. This enabled the authors to include as many as 31 studies in this analysis, 18 of which had not previously published findings on the link between meat consumption and type 2 diabetes. By including this previously unpublished study data the authors considerably expanded the evidence base and reduced the potential for bias from the exclusion of existing research.
Lead author Dr Chunxiao Li, also of the MRC Epidemiology Unit, said: “Previous meta-analysis involved pooling together of already published results from studies on the link between meat consumption and type 2 diabetes, but our analysis examined data from individual participants in each study. This meant that we could harmonise the key data collected across studies, such as the meat intake information and the development of type 2 diabetes.
“Using harmonised data also meant we could more easily account for different factors, such as lifestyle or health behaviours, that may affect the association between meat consumption and diabetes.”
Professor Nick Wareham, Director of the MRC Epidemiology Unit, and a senior author on the paper said: “InterConnect enables us to study the risk factors for obesity and type 2 diabetes across populations in many different countries and continents around the world, helping to include populations that are under-represented in traditional meta-analyses.
“Most research studies on meat and type 2 diabetes have been conducted in USA and Europe, with some in East Asia. This research included additional studies from the Middle East, Latin America and South Asia, and highlighted the need for investment in research in these regions and in Africa.”
InterConnect was initially funded by the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602068.
Reference Li, C et al. Meat consumption and incident type 2 diabetes: a federated meta-analysis of 1·97 million adults with 100,000 incident cases from 31 cohorts in 20 countries. Lancet Diabetes Endocrinol.; 20 August 2024
Adapted form a press release from the MRC Epidemiology Unit
Media enquiries.
Preparing a Monte Cristo Sandwich, with Black Forest Ham
Credit: Lauri Patterson
Sign up to receive our weekly research email.
Our selection of the week's biggest Cambridge research news sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails and then select 'Subscribe'.
I wish to receive a weekly Cambridge research news summary by email.
The University of Cambridge will use your email address to send you our weekly research news email. We are committed to protecting your personal information and being transparent about what information we hold. Please read our email privacy notice for details.
© 2024 University of Cambridge
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .
Aysha karim kiani.
1 Allama Iqbal Open University, Islamabad, Pakistan
2 MAGI EUREGIO, Bolzano, Italy
3 Department of Biological Sciences and chemistry, University of Nizwa, Oman
4 Society and Health, Buckinghamshire New University, High Wycombe, UK
5 School of Food Science and Environmental Health, Technological University of Dublin, Dublin, Ireland
6 Department of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada
7 Department of Ophthalmology, Center for Ocular Regenerative Therapy, School of Medicine, University of California at Davis, Sacramento, CA, USA
8 Department of Philosophy and Applied Philosophy, University of St. Cyril and Methodius, Trnava, Slovakia
9 Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel
10 Institute of Ophthalmology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy
11 MAGI BALKANS, Tirana, Albania
12 Department of Biotechnology, University of SS. Cyril and Methodius, Trnava, Slovakia
13 International Centre for Applied Research and Sustainable Technology, Bratislava, Slovakia
14 UOC Neurology and Stroke Unit, ASST Lecco, Merate, Italy
15 Center for Preclincal Research and General and Liver Transplant Surgery Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
16 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
17 Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
18 UOC Maxillo-Facial Surgery and Dentistry, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
19 Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Cyprus
20 Department of Medical Genetics, Erciyes University Medical Faculty, Kayseri, Turkey
21 Vascular Diagnostics and Rehabilitation Service, Marino Hospital, ASL Roma 6, Marino, Italy
22 MAGI’S LAB, Rovereto (TN), Italy
Kevin donato, maria chiara medori, tommaso beccari.
23 Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
24 MAGI GROUP, San Felice del Benaco (BS), Italy
25 San Francisco Veterans Affairs Health Care System, Department of Oral & Maxillofacial Surgery, University of California, San Francisco, CA, USA
26 Univ. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, SyNaBi, Grenoble, France
27 Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy
28 Department of Biotechnology, University of Tirana, Tirana, Albania
29 Total Lipedema Care, Beverly Hills California and Tucson Arizona, USA
30 Federation of the Jewish Communities of Slovakia
31 Department of Psychological, Health and Territorial Sciences, School of Medicine and Health Sciences, University "G. d'Annunzio", Chieti, Italy
32 Department of Anatomy and Developmental Biology, University College London, London, UK
Matteo bertelli.
33 MAGISNAT, Peachtree Corners (GA), USA
A clinical research requires a systematic approach with diligent planning, execution and sampling in order to obtain reliable and validated results, as well as an understanding of each research methodology is essential for researchers. Indeed, selecting an inappropriate study type, an error that cannot be corrected after the beginning of a study, results in flawed methodology. The results of clinical research studies enhance the repertoire of knowledge regarding a disease pathogenicity, an existing or newly discovered medication, surgical or diagnostic procedure or medical device. Medical research can be divided into primary and secondary research, where primary research involves conducting studies and collecting raw data, which is then analysed and evaluated in secondary research. The successful deployment of clinical research methodology depends upon several factors. These include the type of study, the objectives, the population, study design, methodology/techniques and the sampling and statistical procedures used. Among the different types of clinical studies, we can recognize descriptive or analytical studies, which can be further categorized in observational and experimental. Finally, also pre-clinical studies are of outmost importance, representing the steppingstone of clinical trials. It is therefore important to understand the types of method for clinical research. Thus, this review focused on various aspects of the methodology and describes the crucial steps of the conceptual and executive stages.
How to cite this article: Kiani AK, Naureen Z, Pheby D, Henehan G, Brown R, Sieving P, Sykora P, Marks R, Falsini B, Capodicasa N, Miertus S, Lorusso L, Dondossola D, Tartaglia GM, Ergoren MC, Dundar M, Michelini S, Malacarne D, Bonetti G, Donato K, Medori MC, Beccari T, Samaja M, Connelly ST, Martin D, Morresi A, Bacu A, Herbst KL, Kapustin M, Stuppia L, Lumer L, Farronato G, Bertelli M. Methodology for clinical research. J Prev Med Hyg 2022;63(suppl.3):E267-E278. https://doi.org/10.15167/2421-4248/jpmh2022.63.2S3.30
According to epistemologists, who study the nature, origin and scope of knowledge, epistemic justification, the rationality of belief and related issues [ 1 ], there are six ways to obtain knowledge:
Rationalism and empiricism, pragmatism and scepticism may be within the scope of the scientific method, whereas authoritarianism and mysticism are clearly pseudoscience or anti-science [ 2 ]. Science is characterized by systematic observation and experimentation, inductive and deductive reasoning, and the formation and testing of hypotheses and theories. The details of how these are carried out can vary greatly, but these characteristics are sufficient to distinguish scientific activity from non-science [ 3-8 ]
The choice and selection of a particular methodology depends on factors such as the hypothesis to investigate, the research question or statement of the problem, the objectives, the nature of the study, the study population and controls, intervention and variables [ 9-12 ]. The reliability and validity of the results therefore depend on an overall study design having well-defined objectives, reproducible methodology, diligent data collection and analysis to minimise errors and bias, and efficient reporting of the findings [ 9 , 12 ]. Selecting an appropriate methodology is therefore essential to obtain valid results, and an understanding of research methodology is essential for researchers.
Medical research can be broadly categorised into primary and secondary research. Primary research involves conducting studies and collecting raw data that is then analysed and evaluated in secondary research [ 13 ]. Primary research can be further classified into three types as shown in Figure 1 : basic or laboratory studies, also known as preclinical studies, clinical research, and epidemiological research. Both clinical and epidemiological research involve observational and experimental methods. Clinical research investigates the effects of specific interventions on individuals, while epidemiological research studies the causes and distribution of disease or mortality in human populations, especially the effects of exposure to single or multiple environmental agents [ 14 ]. Similar in essence, clinical research methods differ somewhat, depending on the type of study. Type is an integral element of study design and depends on the research question to answer. It should be specified before the start of any study [ 15 ]. Selecting an inappropriate study type results in flawed methodology, and if it occurs after commencement of the study, it is an error that cannot corrected.
Types of primary medical research.
A clinical research project consists broadly of two stages: planning and action [ 16 ].
The planning stage consists of all the preliminary paperwork and search of the literature done before starting actual research. It includes identifying the problem, reviewing the literature, developing a research question, formulating a hypothesis, determining the type of study, selecting a study design, identifying the target/study population, and seeking informed consent to participation. It also includes establishing collaborations with experts and determining the overall feasibility of the proposed work [ 9 , 16 ].
Before beginning the scientific investigation, the researchers should decide the data collection strategy, sampling techniques and statistical analysis. After choosing a working hypothesis and reformulating it as null and alternative hypotheses, the next step is to decide the type of study required to answer the research question and an appropriate method to implement it.
This stage includes the actionable research, implementation of the method in coherence with the theoretical concept, randomisation, blinding, application of sampling techniques, data collection and statistical analysis [ 10 , 11 ].
Depending on the study design, clinical research can in principle be categorised as either quantitative or qualitative [ 9 ]. Further classification of clinical research methods may be based on data collection techniques and the direction of causality being investigated, as illustrated for example by time relationships. Clinical research can be classified as either descriptive or analytical, as illustrated in Figure 2 [ 9 , 12 , 17-20 ].
Classification of clinical research.
Descriptive studies record and report unusual or new events, e.g. the prevalence of a disease or syndrome in a family, and correlate the events with possible explanations. This type of research is neither randomized nor pre-designed, and is presented as a case report, case series or surveillance study.
These are reports of individual patients with particular clinical characteristics. Such reports present baseline characteristics recorded and evaluated for single patients, compared with population values. Sometimes these studies may consist of observations recorded for administration of a certain treatment to an individual. They are essentially hypothesis generating, opening the way for more rigorous studies of an experimental nature [ 12 ].
Case series may include examination of successive clinical cases having common characteristics. They may, for example, present observations from patients exposed to a particular drug or group of drugs at regular intervals, and may include former histories of patients having similar outcomes, to detect possible cause-effect relationships.
This type of study involves continuous monitoring of disease occurrence in a population. Information related to a health problem of interest is collected in databases, analysed over a time period and inferences are made based on observed correlations.
The most significant difference between descriptive and analytical studies is the presence in the latter of control groups that enable comparative evaluations to be made. Analytical clinical studies can be further classified into experimental (intervention) studies and observational (non-intervention) studies.
Observational studies are non-intervention studies in which patients are prescribed a specified therapy based on diagnosis and therapeutic need. They include therapeutic, prognostic, observational drug studies, secondary data analyses, case series and single case reports, and may be retrospective, prospective or ambidirectional [ 21 ]. In non-intervention studies, “knowledge from the treatment of persons with drugs in accordance with the instructions for use specified in their registration is analysed using epidemiological methods” [ 21 ]. “Diagnosis, treatment and monitoring are not performed according to a previously specified study protocol, but exclusively according to medical practice” [ 21 ].
Observational studies involve collecting data pertaining to study participants in their natural or real-world environments. They are usually diagnostic and prognostic studies, with a cross-sectional approach to data collection. The comparative-effectiveness study is the hallmark of non-experimental research [ 22 ], and involves comparison of comparable groups to interpret outcome effects. Such studies are also known as benchmarking-controlled trials because of the element of peer comparison [ 22 ].
Observational studies can be broadly categorised into individual and aggregate studies.
Individual level data aggregated by geographic area, year or any other parameter is termed aggregate data. Aggregate studies are conducted to record observations on pandemics and epidemics of communicable diseases and their treatment regimens, for example aggregate data on COVID-19 in a particular country, or the occurrence and effective treatment of malaria and its relapse in a particular geographical area. Data pertaining to non-communicable diseases is also aggregated in the same way to generate insights into the distribution of diseases in specified populations, as for example in cancer registries [ 23 , 24 ].
Individual studies are based on disaggregated individual results and involve analysis to estimate differences between subgroups. In individual observational studies, subjects are observed individually and then gathered in groups based on outcomes or exposures or both. Based on grouping criteria, individual observational studies may take the form of case-control, cohort or cross-sectional studies.
Individual observational studies that involve grouping of subjects based on selected outcomes are termed case-control studies. In these studies, the exposure experience of the case group (subjects with the outcome of interest) is compared with that of the control group (subjects without the outcome), for instance occurrence or non-occurrence of renal failure in diabetic patients or heart attacks in hypertensive patients. The design of such studies is retrospective and evaluates possible associations between exposures and outcome. They are quick and inexpensive to perform, and the results are expressed as odds ratios (OR) and risk ratio/relative risk. Case control studies enable multiple exposure variables to be examined for a given outcome, but they do not allow correlation of sequential causes and effects with the outcome [ 12 ].
In this type of study subjects are grouped based on exposure. Cohort studies enable multiple outcomes to be studied for a given exposure. The exposure is well-defined, but the outcome may vary, thus providing an opportunity to monitor many outcomes of a single exposure [ 12 ]. Cohort studies can be retrospective, where the cohorts are defined on the basis of a past exposure, or prospective, where the cohorts are defined by a current exposure.
In retrospective cohort observational studies, the researchers look back in time at archived or self-reported data in order to compare outcomes in exposed and non-exposed patients. The two groups are identified retrospectively and studied prospectively. This type of study is quick and inexpensive [ 25 , 26 ], but is prone to recall-bias [ 27 ].
A prospective cohort study is a longitudinal cohort study in which cohorts differing in exposure to the factors being studied are followed up at predetermined time intervals to determine the effect on outcomes. This type of study helps to determine associations between a particular exposure and outcomes. For rare outcomes, large numbers of subjects and long follow-up periods are required, so such studies tend to be very expensive. In addition, if randomization and blinding are not conducted properly, the chances of bias and confounders increases [ 26 ].
Cross-sectional studies have transverse study design and involve concurrent assessment of exposures and outcomes without any follow-up. These studies are essentially based on surveys, and are therefore appropriate for determining prevalence but cannot shed light on causation [ 12 , 26 ].
Experimental studies are intervention studies, and include preclinical trials on animals as well as clinical trials in humans. In these studies, the effect of an intervention is compared with that of another intervention or a placebo. Interventions studied may include, for example, use of medical devices, surgical, physical or psychotherapeutic procedures, psychosocial interventions, rehabilitation measures, acupuncture, physiotherapy training or diet [ 1 , 14 ]. Experimental studies mostly aim to compare outcomes of treatment procedures in a group of patients exhibiting minimal internal differences. To avoid bias, patients are randomly allocated to treatment and control groups. Different countries have different procedures and legal and ethical requirements governing the conduct of such studies. For instance, the United Kingdom Medicines and Medical Devices Act 2021 requires that studies using medical devices be registered by the relevant authorities. In the European Union, interventional studies must be conducted in accordance with the binding rules of Good Clinical Practice (GCP) [ 28 ]. In Germany, vaccine studies are considered to be intervention studies and are conducted as clinical studies according to the AMG [ 13 ]. Likewise, drug studies must seek approval from ethical committees. Informed consent must be obtained from the patient and an ethically defensible control group included. The control group is given another treatment regimen and/or placebo and should enable the central questions of the study to be answered [ 28 ].
Some experimental studies in biomedical research may focus on possible biomarkers, such as enzymes or genes, on evaluation of imaging techniques, such as magnetic resonance imaging and computed tomography, or on techniques such as gene sequencing in order to find correlations between genotypes and phenotypes. The development of statistical tests and mathematical models may also be regarded as experimental studies. Generally, the design of biomedical studies should be based on their purpose and objectives [ 13 ].
The design of an experimental study depends on the type of information sought, the objectives of the study and the ultimate application. Designs can be characterized by interventions on selected groups of the study population under controlled environmental conditions compared with a control group without any interventions. The main designs employed in experimental studies are randomised controlled trials and non-randomised clinical trials, also known as quasi-experimental studies [ 9 , 12 , 26 ].
In non-randomised studies, the study population is selected on the basis of pre-determined selection criteria; it is not randomized with respect to treatment(s) but is prescribed treatment based on the course of the disease. In many experimental studies involving surgical intervention which is only appropriate for particular patient groups, randomization is either not possible or not ethical. Generally, phase IV of a clinical trial has non-randomized design. Non-randomised studies can be further categorised as:
The investigator assigns exposure to the intervention as in a randomized controlled trial, but the subjects are not randomized [ 12 ].
These are large scale studies of therapeutic interventions, for example the efficacy of COVID-19 vaccines in combatting COVID-19. Many samples are required to determine efficacy, particularly when the incidence of a particular disease in the population is low [ 26 ].
In these trials, treatments are allocated to a community group. For instance, the effect of fluoridation of water was tested by exposing some communities to fluoride and comparing outcomes with those in unexposed communities.
Randomised controlled trials (RCTs) are trials in which the subjects are randomly assigned to experimental and control groups. The experimental group is given the treatment that is being tested and the control group is given an alternative treatment or a placebo or no treatment at all. Most experimental clinical studies are RCTs, and the subjects are either healthy volunteers or patients. After a new drug passes a pre-clinical trial, it is tested via RCTs. Various aspects of the RCT require careful consideration before the trial begins, for example study design, patient population, control group selection, randomization, sampling, blinding or open labelling of treatments and outcomes [ 12 , 26 ].
Study design is an important prerequisite for the success of the study. Randomised controlled trials commonly use parallel group design, matched pairs and cross-over designs [ 29 ].
This design requires large number of subjects/patients who are enrolled, followed up and observed for outcomes on a parallel basis over a period of time.
In this design, patients are matched for different variables. Matched subjects are assigned at random to intervention or control groups. Although this type of design is difficult to conduct, it helps overcome the influence of confounding variables on outcomes.
This design is used for drugs having reversible and transient effects. The effects of two interventions, administered sequentially, are assessed. The number of patients required is smaller than for the other designs [ 29 ].
In RCTs, the patient population is selected on the basis of predetermined selection criteria. This selection is carried out to avoid confounding variables and should be based on predefined inclusion and exclusion criteria. Withdrawal criteria, indicating the circumstances under which subjects should be withdrawn from the trial, should also be predefined.
The criteria for selection of subjects (patients or healthy volunteers) are based on age, body mass index, gender, ethnicity, prognostic factors and diagnostic admission criteria. They are used to select the subjects and then randomly assign them to various treatments for comparison of outcomes [ 26 , 30 ].
These are criteria for excluding subjects from a particular trial, for example severity of disease, concurrent medication, allergies, underlying health conditions and many more [ 30 ].
These indicate situations in which the trial is terminated for particular subjects and specify how and when the subjects should be withdrawn from the study. When subjects are withdrawn, they are no longer subject to follow-up.
Perhaps the most important factor in any scientific research is identification and determination of a control group. Without successful deployment of a control group, a study cannot be authentic. Randomised controlled trials can include placebo, no-treatment, historical or active controls [ 26 ].
A placebo is a fake or inert version of the drug under evaluation, with no pharmacological effect. Placebos help overcome any psychological impact of drug dispensing on disease progression, allowing the investigator to estimate the effectiveness of a treatment free from confounding psychological factors. However, placebo controls in drug research and sham surgery are ethically controversial, especially in cases where an effective treatment exists.
This is the least preferred type of control, where subjects are not given anything by way of treatment, not even a placebo. Such controls serve as a neutral reference group for the experimental groups receiving the treatment under investigation. This approach avoids bias due to psychological factors that may influence outcomes.
In some studies, concurrent controls are dispensed with and only historical control data is used. This is done specifically for studies involving rare diseases with high mortality. In such circumstances, withholding treatment from a control group would raise very considerable ethical implications [ 9 ]. Historical controls are controls used in previous studies. They help reduce the overall cost of the study, making drug developers more likely to invest. Historical controls also make enrolment in rare disease trials more feasible by reducing the number of patients required.
Randomization is the optimal method of allocating subjects to the therapy arms of a trial. Random assignment of subjects to the treatment and control groups ensures equal distribution of all variables and confounding factors, such as genetic variabilities, risk factors and comorbidities, in all groups, thereby alleviating bias. Randomization is intended to ensure comparability between the groups, and it reduces the chance of allocating a specific therapy to patients with a particularly favourable prognosis. Randomization is carried out using random number tables, mathematical algorithms for pseudorandom number generation, physical randomization devices such as coins and cards, or sophisticated devices such as electronic random number indicator equipment [ 9-12 , 26 ].
The main randomization techniques used in RCTs are simple randomization, cluster randomization and stratified randomization [ 31 ].
Randomization involving a single sequence of random assignments is known as simple randomization. It randomizes patients selected on the basis of selection criteria to various treatment groups.
Cluster-randomized trials are used to compare treatments that are allocated to clusters (groups) of subjects, rather than to individuals. Groups of patients matching the selection criteria are randomly assigned to the group receiving the treatment or to a control group. Randomised controlled trials are used to evaluate complex interventions.
This is a two-step procedure. As the name indicates, the subjects entering the clinical trial are first grouped in strata (groups) based on clinical features that might affect the outcome of their condition, and then undergo intra-group randomization to assign them to various treatment groups.
Sampling is the process of selecting a sample population from the target population. Sampling allows information to be obtained about the target population based on statistical analysis of a subset of the population, without any need to investigate the characteristics of every individual in the target population [ 32 ]. Sampling techniques are broadly categorised into probability and non-probability sampling, as shown in Figure 3 .
Sampling methods in clinical research.
In this sampling technique, every element of the population has an equal chance of being selected. This helps create a sample truly representative of a given population [ 22 ]. Types of probability sampling techniques are:
In this type of sampling every experimental unit has an equal chance of being selected during sampling.
This sampling is used where a complete and up-to-date sampling frame is available. The first experimental unit is selected randomly, while the rest are selected randomly based on a predesigned pattern.
In this method the study population is divided into strata according to age, gender etc. and then sampling is carried out from these strata.
In this method the study population is divided into clusters and these clusters rather than individuals are taken as sampling units. The clusters are then randomly selected for inclusion in the study.
Multistage random sampling is conducted at several stages within population clusters. This sampling method is usually applied to large nationwide surveys.
The sampling is conducted in two or more phases. In the first phase some data is collected from the whole sample and in the second, data is collected from a subset of the original sample.
In this type of sampling technique, not all experimental units get an equal chance of being selected [ 22 ]. A non-representative sample which does not produce generalizable results is a possible result. Different types of non-probability sampling are:
This sampling is based on the convenience of the investigator.
This type is based on the judgement of the investigator.
This method of sampling is used in studies involving interviews and is based on the judgment of the interviewers, depending on characteristics such as sex and physical status.
Blinding is defined as “concealing or masking the assignment of subjects to a study group from the participants of the study, i.e., patients/subjects, observers and researchers”. Randomised clinical trials may be blinded or non-blinded [ 9 , 12 , 26 ].
Non-blinded experiments are also known as open-label studies. In this type of study, all participating patients, physicians, observers and researchers know the treatment used. This may result in bias, but is unavoidable where hiding a treatment raises ethical concerns. For instance, it is unethical to hide the treatment regime from patients with cancer, AIDS or organ failure. Patients may also be allowed to select the drug brand themselves.
In these experiments the blinding is done at the start of the experiment. Blinding can be single, double or triple.
The subjects (patients or healthy volunteers) do not know whether they are in the intervention or the placebo group.
Neither the subjects nor the researcher knows who has been assigned to the control and the test groups. Only the observer knows to which group the subjects have been assigned.
In triple blind RCTs, personal or intentional bias is eliminated by none of the study participants (subjects, observer, researcher) knowing the label or nature of the treatment administered.
The information identifying treatment and subjects in double- and triple-blind experiments is held by another party and only made available to the researcher at the end of the trial.
Randomized controlled trials can be conducted as PROBE trials in which patients are randomly assigned to different treatment regimens and both patients and researchers are aware of the treatments administered. The PROBE trial is much easier to conduct than double- or triple-blind or doubled-blind placebo-controlled design, as it enables trials to be performed in conditions that resemble real-world practice. It is also economical and simplifies patient enrolment. However, it imposes certain conditions to avoid the bias associated with open label trials. PROBE designs are endpoint blinded, as the observer is unaware of the treatment being used. Since the subjects and researchers know the treatments, potential bias can be avoided by using so-called hard endpoints as primary endpoints. However, the results obtained by PROBE are less reliable than those obtained by double- or triple-blind studies [ 33 ].
Another important prelude to a successful clinical study is the selection of treatment dosage, form, frequency, route of administration and concurrent medications for the test and active control groups. A drug may be available in various doses and in forms such as tablet, capsule or injectable. Since these factors affect the plasma concentrations and effects of the drug, and ultimately the outcome; all these factors, except dose and frequency, are maintained constant throughout the study. If necessary, the dose and frequency of the drug may be changed gradually and sequentially. If the treatments involve more than one drug, their pharmacokinetic and pharmacodynamic interactions are kept under observation while determining dosage, in order to avoid any influence of these interactions on outcomes [ 9 , 12 , 33 ]. Another important consideration in treatment selection is patient compliance, since non-compliance may have adverse effects on outcome.
Since the objectives of a clinical study indicate the possible outcomes, this is borne in mind in selecting the methods of monitoring and the data required for recording the outcomes of interest. In clinical experiments, outcomes are assessed in terms of efficacy endpoints, i.e. primary endpoints and surrogate or secondary endpoints. Primary endpoints are measures specified by the researcher at the start of the study in order to verify or refute the hypothesis, whereas surrogate endpoints are specified before commencement of the study but can be modified during its course. For instance, in an experiment estimating the efficacy of an antihypertensive drug, the primary endpoint would be to see whether or not the treatment reduces cardiovascular events, while a surrogate endpoint could be its ability to reduce blood pressure [ 26 ]. Many primary and secondary endpoints are prespecified before beginning a study. However, the main primary endpoint is the quality of life afforded by a particular treatment for individuals in the study group.
Bias is distortion of outcomes due to introduction of errors, voluntarily or involuntarily, at different stages of the research, e.g. the stages of design, population selection, calculation of number of samples, data entry and statistical analysis. Several types of bias can occur during clinical research ( Tab. I ).
Types of bias in clinical research.
Type of Bias | Description |
---|---|
Conscious or unconscious preference given to one group over another by the investigator | |
Introduced when an investigator making endpoint-variable measurements favours one group over another. Common with subjective endpoints | |
Introduced when participants know their allocation to a particular group and change their response or behaviour during a particular treatment | |
Introduced when samples (individuals or groups) are selected for data analysis without proper randomization; includes admission bias and non-response bias, in which case the sample is not representative of the population | |
Errors in measurement or classification of patients; includes diagnostic bias and recall bias | |
Systematic differences in the allocation of participants to treatment groups and comparison groups, when the investigator knows which treatment is going to be allocated to the next eligible participant | |
Information is processed in a manner consistent with someone’s belief | |
The strength of arguments is judged on the basis of the plausibility of their conclusions rather than how strongly they support that conclusion. | |
Introduced during publication by a personal preference for positive results over negative results when the results deviate from expected outcomes | |
Systematic errors in observation of outcomes in different groups results in detection bias when outcomes in one group are not as vigilantly sought as in the other. | |
Preferential loss-to-follow-up in a particular group leads to attrition bias. | |
Introduced for commercial reasons in the form of advertising or economic pressure on editors, particularly in studies involving new medical devices and drugs |
Chicanery involves deliberate unethical changes to interventions, results and the data of patients. Copying data from other sources is also classified as chicanery.
Confounders are factors, other than those being studied, that can affect an outcome parameter. These factors are not directly relevant to the research question but may possibly alter the outcomes [ 10 , 11 ]. For example, while studying the effect of hypertension on renal failure, diabetes could be a confounder as it also affects kidney function. It is therefore essential to take all potential confounders into consideration when designing a study. If known, confounders can be controlled for by selection constraints or statistical adjustments, such as stratification and mathematical modelling, during study design. Various strategies are used during data analysis to adjust for confounders; these include stratified analysis using the Mantel-Haenszel method, a matched design approach, data restriction and model fitting using regression techniques [ 34 ].
Bias, chicanery and confounders can be avoided by randomization and blinding. The randomized controlled and blinded clinical trial with case number planning is therefore accepted as the gold standard for evaluating the efficacy and safety of drugs and therapeutic regimes [ 35 ].
The results of a clinical trial are said to be valid if the differences observed between the study and control groups are real and not influenced by bias or confounders (internal validity) and are applicable to a broader population (external validity). Placebo-controlled, double-blinded, randomised clinical trials have high internal validity, while external validity can be increased by broadening the eligibility criteria for enrolling subjects [ 36 ].
Pre-clinical (or laboratory) studies form the basis of clinical trials. To reduce the time for, and to improve the chances of approval of a new drug, the choice of an appropriate preclinical model is of utmost importance. Preclinical studies evaluate the pharmacodynamics, pharmacokinetics and toxicology of a drug in in vitro and in vivo settings. Clinical trials are conducted when preclinical studies have demonstrated the efficacy and safety of a new drug. The results of clinical trials can improve preclinical studies and vice versa . Nonetheless, only a small fraction of drugs that pass the preclinical evaluation criteria are selected for clinical trials, and only a few are approved for use in humans, so optimization of standard preclinical procedures to mimic the complexity of human disease mechanisms is urgently needed [ 37 ].
In summary, preclinical studies involve the use of various in vivo and in vitro models and computer designs to evaluate the efficacy and safety of a new drug.
Advances in cell culture technology have made it possible to test new drugs on cell lines grown in vitro. These studies may involve testing of drugs on human or animal cancer cells [ 38 ].
Drugs that prove effective in vitro are then tested in vivo in live animals to ensure their safety in living systems. Animal models, and their critical validation, are of great importance in minimizing unpredicted adverse effects of a drug in clinical trial phases. Animal models are carefully selected on the basis of their advantages and limitations and on the objectives of the study, in order to mimic pathophysiological conditions in humans [ 38 ]. The validity of animal models is increased by following the relevant guidelines and standards in designing a study. Three types of models are used in preclinical studies:
Homologous models are animals which have the same causes, symptoms, and treatments of a particular disease that humans would have.
These animals have same symptoms and treatments of a particular disease as humans, but the cause may be different.
These models are only like humans in some aspects of a particular disease; however they provide useful information about the mechanisms of disease features.
In silico models are based on computer simulations that complement or precede in vitro and in vivo studies. They predict how a drug might behave in these subsequent studies. In-silico studies require expertise in biochemistry, molecular biology, cheminformatics, and bioinformatics [ 38 ].
Pre-clinical studies provide useful information about the behaviour and safety of drugs. However, drugs do not necessarily behave in the same way in humans as they do in animal models. For example, human subjects and mice models differ sharply in absorption, processing, and excretion of certain drugs. Unexpected side-effects may therefore occur in humans that do not occur in animal models. Drugs which show promising outcomes in preclinical studies are then approved for testing in human subjects by regulatory authorities such as the Food and Drug Administration (FDA) in the US [ 37 , 38 ].
Once preclinical studies on a new drug are completed and promising results are achieved, the next stage in biomedical research is testing the safety, efficacy and reproducibility of the drug’s action on humans through clinical trials. Clinical trials are considered to be a safe and dependable method of evaluating the efficacy of a treatment. Clinical trials may be therapeutic or preventive [ 37-39 ].
These trials are conducted to test experimental treatments, combinations of new or existing drugs, and new surgical interventions.
These trials test the efficacy of interventions (drugs, vaccines) in preventing diseases and their outcomes.
In general, clinical trials aim to enhance the repertoire of information related to an intervention or lifestyle regime that might prove beneficial for patient management or treatment. They are designed to develop and test new diagnostic methods or treatments and their effects on humans, or new uses of existing diagnostic methods or treatment. They also help identify the most cost-effective and risk-free diagnostic methods or treatments. Randomized controlled trials are conducted to compare the safety and efficacy of two or more interventions in humans, and can often be based on clinical equipoise. Their phases [ 26 ] are shown in Table II .
Phases of a randomized controlled trial of a drug.
Phases | Aim | Number of participants |
---|---|---|
To check the | a few volunteers | |
To check | 20-80 healthy volunteers or patients in an advanced stage of disease | |
To assess | Hundreds of volunteers | |
To | Hundreds to thousands of volunteers | |
To collect more information on | Hundreds of thousands of volunteers |
Clinical trials are the gold standard for evaluating the superiority or similarity of new drugs or surgical procedures with respect to existing ones. As clinical trials involve testing on humans, their design and conduct require careful planning, diligent execution and enormous resources to comply with regulations set by the regulatory authorities so that robust results can be attained. The good clinical practice (GCP) guidelines published by the International Council of Harmonization (ICH) is an international ethical standard that ensures that the design, conduct, performance, monitoring, auditing, recording, analysis and reporting of clinical trials takes place according to established values. It also ensures the reliability and precision of reported data, and protects the rights, integrity and privacy of subjects participating in a trial [ 28 , 31 ]. Protection of the safety, wellbeing and rights of human subjects participating in a clinical trial is consistent with the principles of the Declaration of Helsinki [ 40 ] and with the ethical principles formulated by the World Medical Association [ 41 ]. The requirements for conducting clinical trials in the European Union, including GCP and good manufacturing practice and their respective inspections, are implemented in the Clinical Trial Directive (Directive 2001/20/EC) and the Good Clinical Practice Directive (Directive 2005/28/EC) [ 31 ].
The responsibility for GCP lies with all participants in the trial, from the site staff to the subjects and the ethical and monitoring committees. The roles and responsibilities of GCP participants are shown in Table III .
Clinical trial participants and their role in good clinical practice.
Participants | Role |
---|---|
Regulatory authorities | Review clinical data and conduct inspections for GCP and good manufacturing practice |
Sponsor | Institution/organization responsible for initiation, management and finance of clinical trial |
Project monitor | Monitors the project and is appointed by the sponsor |
Investigator | Team leader responsible for conducting trial at trial site |
Trial site pharmacist | In charge of maintaining, storing and dispensing drugs |
Patients | Human subjects |
Ethical review committee for the protection of subjects | Institutional or national regulatory authorities ensuring safety, well-being and protection of human subjects |
Committee to monitor large trials | Overseas sponsors, drug companies |
The planning and execution of clinical research is of vital importance for the advancement of medical science. The validity of clinical research findings depends on a variety of factors, such as study design, sampling techniques and statistical analysis. Choosing an appropriate study design requires detailed knowledge of the types of clinical study, the situations where they are applied and the possible outcomes, so that a methodology befitting the hypothesis is adopted. Careful implementation of study design eliminates the chances of bias, provides quality assurance of the data collected and increases the validity of the results, adding value to the findings. Successful preclinical studies, basic research and pilot scale intervention studies pave the way for more sophisticated clinical trials. Randomised, double-blind clinical trials with case number planning are accepted as the gold standard for evaluating the efficacy and safety of drugs and therapeutic regimes and in evaluating the superiority or similarity of new drugs or surgical procedures to existing ones. As clinical trials involve testing on humans, their design and conduct require careful planning, diligent execution and enormous resources to comply with the rules set by the regulatory authorities, necessary to achieve robust results.
This research was funded by the Provincia Autonoma di Bolzano in the framework of LP 15/2020 (dgp 3174/2021).
Authors declare no conflict of interest.
MB: study conception, editing and critical revision of the manuscript; AKK, DP, GH, RB, Paul S, Peter S, RM, BF, NC, SM, LL, DD, GMT, MCE, MD, SM, Daniele M, GB, KD, MCM, TB, MS, STC, Donald M, AM, AB, KLH, MK, LS, LL, GF: literature search, editing and critical revision of the manuscript. All authors have read and approved the final manuscript.
Contributor information.
INTERNATIONAL BIOETHICS STUDY GROUP : Derek Pheby , Gary Henehan , Richard Brown , Paul Sieving , Peter Sykora , Robert Marks , Benedetto Falsini , Natale Capodicasa , Stanislav Miertus , Lorenzo Lorusso , Gianluca Martino Tartaglia , Mahmut Cerkez Ergoren , Munis Dundar , Sandro Michelini , Daniele Malacarne , Tommaso Beccari , Michele Samaja , Matteo Bertelli , Donald Martin , Assunta Morresi , Ariola Bacu , Karen L. Herbst , Mykhaylo Kapustin , Liborio Stuppia , Ludovica Lumer , and Giampietro Farronato
share this!
August 21, 2024
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
written by researcher(s)
by Chelsea Reynolds, The Conversation
It's one of the most pervasive messages about technology and sleep. We're told bright, blue light from screens prevents us falling asleep easily. We're told to avoid scrolling on our phones before bedtime or while in bed . We're sold glasses to help filter out blue light. We put our phones on "night mode" to minimize exposure to blue light.
But what does the science actually tell us about the impact of bright, blue light and sleep? When our group of sleep experts from Sweden, Australia and Israel compared scientific studies that directly tested this, we found the overall impact was close to meaningless. Sleep was disrupted, on average, by less than three minutes.
We showed the message that blue light from screens stops you from falling asleep is essentially a myth, albeit a very convincing one.
Instead, we found a more nuanced picture of technology and sleep.
We gathered evidence from 73 independent studies with a total of 113,370 participants of all ages examining various factors that connect technology use and sleep.
We did indeed find a link between technology use and sleep, but not necessarily what you'd think.
We found that sometimes technology use can lead to poor sleep and sometimes poor sleep can lead to more technology use. In other words, the relationship between technology and sleep is complex and can go both ways.
Technology is proposed to harm our sleep in a number of ways. But here's what we found when we looked at the evidence:
Bright screen light—across 11 experimental studies, people who used a bright screen emitting blue light before bedtime fell asleep an average of only 2.7 minutes later. In some studies, people slept better after using a bright screen. When we were invited to write about this evidence further, we showed there is still no meaningful impact of bright screen light on other sleep characteristics including the total amount or quality of sleep
Arousal is a measure of whether people become more alert depending on what they're doing on their device. Across seven studies, people who engaged in more alerting or "exciting" content (for example, video games) lost an average of only about 3.5 minutes of sleep compared to those who engaged in something less exciting (for example, TV). This tells us the content of technology alone doesn't affect sleep as much as we think
Research we reviewed suggests people tend to use more technology at bedtime for two main reasons:
There are also a few things that might make people more vulnerable to using technology late into the night and losing sleep.
We found people who are risk-takers or who lose track of time easily may turn off devices later and sacrifice sleep. Fear of missing out and social pressures can also encourage young people in particular to stay up later on technology.
Last of all, we looked at protective factors, ones that can help people use technology more sensibly before bed.
The two main things we found that helped were self-control , which helps resist the short-term rewards of clicking and scrolling, and having a parent or loved one to help set bedtimes .
The blue light theory involves melatonin, a hormone that regulates sleep. During the day, we are exposed to bright, natural light that contains a high amount of blue light. This bright, blue light activates certain cells at the back of our eyes, which send signals to our brain that it's time to be alert. But as light decreases at night, our brain starts to produce melatonin, making us feel sleepy.
It's logical to think that artificial light from devices could interfere with the production of melatonin and so affect our sleep. But studies show it would require light levels of about 1,000–2,000 lux (a measure of the intensity of light) to have a significant impact.
Device screens emit only about 80–100 lux . At the other end of the scale, natural sunlight on a sunny day provides about 100,000 lux .
We know that bright light does affect sleep and alertness. However, our research indicates the light from devices such as smartphones and laptops is nowhere near bright or blue enough to disrupt sleep.
There are many factors that can affect sleep, and bright, blue screen light likely isn't one of them.
The take-home message is to understand your own sleep needs and how technology affects you. Maybe reading an e-book or scrolling on socials is fine for you, or maybe you're too often putting the phone down way too late. Listen to your body and when you feel sleepy, turn off your device.
Explore further
Feedback to editors
4 hours ago
5 hours ago
6 hours ago
7 hours ago
8 hours ago
Jul 25, 2024
Jul 18, 2024
May 28, 2024
Aug 11, 2023
Mar 1, 2024
Apr 26, 2021
11 hours ago
16 hours ago
Aug 20, 2024
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form . For general feedback, use the public comments section below (please adhere to guidelines ).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties.
More information Privacy policy
We keep our content available to everyone. Consider supporting Science X's mission by getting a premium account.
Consuming meat, particularly red and processed meat, and even poultry like chicken and turkey may increase the risk of developing type 2 diabetes in the future, according to a new study published on Tuesday, adding to growing evidence linking meat and ultra-processed foods to health issues including heart disease, cancer, depression, anxiety and even premature death.
Red meat is associated with a higher risk of type 2 diabetes, researchers found.
Consuming processed meat and unprocessed red meat regularly is associated with a higher risk of developing type 2 diabetes, according to peer reviewed published in The Lancet Diabetes and Endocrinology medical journal.
While previous research has indicated eating more processed meat and unprocessed red meat is linked to a higher risk of type 2 diabetes, the researchers said results have been inconclusive and variable, which has led to confusing and often polarizing debates over whether the foods are safe to eat and, if so, in what quantities.
To assess the link between meat and the risk of type 2 diabetes, the team, led by researchers at the University of Cambridge, analyzed existing data from nearly 2 million people across 31 study groups in 20 countries to see whether their eating habits were associated with a risk of type 2 diabetes when accounting for other factors like age, gender, energy intake, body mass index and health-related behaviors.
Habitually eating 50 grams of processed meat a day—roughly equivalent to two slices of ham—was associated with a 15% higher risk of developing type 2 diabetes in the next 10 years, the researchers found, and consuming 100 grams of unprocessed red meat a day—the equivalent of a small steak—was associated with a 10% higher risk.
Nita Forouhi, a professor of population health and nutrition at the University of Cambridge and a senior author on the paper, said the research “provides the most comprehensive evidence to date” of a link between eating red and processed meat and a higher future risk of type 2 diabetes.
“It supports recommendations to limit the consumption of processed meat and unprocessed red meat to reduce type 2 diabetes cases in the population,” added Forouhi.
Poultry such as chicken, turkey and duck is often touted as a healthier protein source to red and processed meats. The idea is supported by research, which indicates lower risks for many of the health issues linked to red and processed meat consumption like cancer , heart disease and diabetes , but the issue is a comparative one and it does not mean eating poultry is without risk. Research increasingly indicates regular poultry meat consumption is linked to harmful health effects like gastro-oesophageal reflux disease, gallbladder disease and diabetes. Research on this association is more limited, the researchers noted, taking the opportunity to investigate the potential link as well. They found habitual consumption of 100 grams of poultry a day was associated with an 8% higher risk of developing type 2 diabetes over the next 10 years. However, Forouhi warned the evidence linking poultry consumption and diabetes was much weaker than that for red and processed meat when subjected to further analytical scrutiny. “While our findings provide more comprehensive evidence on the association between poultry consumption and type 2 diabetes than was previously available, the link remains uncertain and needs to be investigated further,” Forouhi said.
While often considered a “white meat” alongside poultry like chicken, experts and regulators say pork is a “red meat” like beef, veal and lamb. The U.S. Department of Agriculture says the distinction is determined by the amount of the oxygen-carrying protein myoglobin is in the meat, which determines the color of the meat. Pork is considered red meat because it contains more myoglobin than chicken or fish.
Growing evidence on the negative health associations of eating different meats has ignited campaigns to limit the consumption of red and processed meat, and sometimes meat in general, as a matter of public health and to reduce the burden of diseases like diabetes. In recent years, this health-driven messaging has been joined by a more climate-focused approach, urging people to limit meat consumption as part of reducing their carbon footprint and tackling the climate crisis. Research has also increasingly identified potential health problems like heart disease and early death linked to ultraprocessed foods, including plant-based ultraprocessed foods .
Most research between food consumption and various health risks are observational in nature. This means causal relationships are very hard to determine. More research—much of which would be difficult or impossible to conduct in humans—is needed to establish causal claims like reducing red meat intake will reduce the risk of developing diabetes.
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here .
One Community. Many Voices. Create a free account to share your thoughts.
Our community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.
In order to do so, please follow the posting rules in our site's Terms of Service. We've summarized some of those key rules below. Simply put, keep it civil.
Your post will be rejected if we notice that it seems to contain:
User accounts will be blocked if we notice or believe that users are engaged in:
So, how can you be a power user?
Thanks for reading our community guidelines. Please read the full list of posting rules found in our site's Terms of Service.
IMAGES
COMMENTS
The article is based on a selective literature research on study types in medical research, as well as the authors' own experience. Classification of study types. In principle, medical research is classified into primary and secondary research. While secondary research summarizes available studies in the form of reviews and meta-analyses, the ...
Types of study design. Medical research is classified into primary and secondary research. Clinical/experimental studies are performed in primary research, whereas secondary research consolidates available studies as reviews, systematic reviews and meta-analyses. Three main areas in primary research are basic medical research, clinical research ...
There are various types of scientific studies such as experiments and comparative analyses, observational studies, surveys, or interviews. The choice of study type will mainly depend on the research question being asked. When making decisions, patients and doctors need reliable answers to a number of questions. Depending on the medical condition and patient's personal situation, the following ...
Basic medical research is usually conducted by scientists with a PhD in such fields as biology and chemistry, among many others. They study the core building blocks of life — DNA, cells, proteins, molecules, etc. — to answer fundamental questions about their structures and how they work. For example, oncologists now know that mutations in ...
Introduction. Study designs are frameworks used in medical research to gather data and explore a specific research question.. Choosing an appropriate study design is one of many essential considerations before conducting research to minimise bias and yield valid results.. This guide provides a summary of study designs commonly used in medical research, their characteristics, advantages and ...
An observational study is a study in which the investigator cannot control the assignment of treatment to subjects because the participants or conditions are not directly assigned by the researcher.. Examines predetermined treatments, interventions, policies, and their effects; Four main types: case series, case-control studies, cross-sectional studies, and cohort studies
Below are descriptions of some different kinds of clinical research. Treatment Research generally involves an intervention such as medication, psychotherapy, new devices, or new approaches to ...
Clinical research is the comprehensive study of the safety and effectiveness of the most promising advances in patient care. Clinical research is different than laboratory research. It involves people who volunteer to help us better understand medicine and health. Lab research generally does not involve people — although it helps us learn ...
Health research methodology: A guide for training in research methods Chapter 1 Research and Scientific Methods 1.1 Definition Research is a quest for knowledge through diligent search or investigation or experimentation aimed at the discovery and interpretation of new knowledge. Scientific method is a systematic
Introduction to Types of Medical Research. Evidence-based medicine may be defined as the systematic, quantitative and preferentially experimental approach to obtaining medical information. This information is obtained through medical research. Medical research encompasses a wide range of study techniques that can be used to understand diseases ...
Background: The choice of study type is an important aspect of the design of medical studies. The study design and consequent study type are major determinants of a study's scientific quality and clinical value. Methods: This article describes the structured classification of studies into two types, primary and secondary, as well as a further subclassification of studies of primary type.
Clinical research is research conducted with human subjects, or material of human origin, in which the researcher directly interacts with human subjects. Clinical researchers at the National Human Genome Research Institute (NHGRI) are developing advanced methods for studying the fundamental mechanisms of inherited and acquired genetic disorders.
Often used in the medical sciences, but also found in the applied social sciences, a cohort study generally refers to a study conducted over a period of time involving members of a population which the subject or representative member comes from, and who are united by some commonality or similarity. ... Mixed methods research represents more of ...
Publication types. Review. Medical research has evolved, from individual expert described opinions and techniques, to scientifically designed methodology-based studies. Evidence-based medicine (EBM) was established to re-evaluate medical facts and remove various myths in clinical practice. Research methodology is now protocol ….
Here, the goal is to find strategies that can be used to address a specific research problem. Applied research draws on theory to generate practical scientific knowledge, and its use is very common in STEM fields such as engineering, computer science and medicine. This type of research is subdivided into two types:
Primary medical research is categorized into three main fields: laboratorial, clinical, and epidemiological. Laboratory scientists analyze the fundamentals of diseases and treatments. Clinical researchers collaborate with participants to test new and established forms of treatment. Epidemiologists focus on populations to identify the cause and ...
This type of research can be one or a combination of the types of research mentioned above. Public health research tries to improve the health and well-being of people from a population-level perspective. ... Subjects: Dental Medicine, Medicine, Public Health, Research Methods.
Quantitative research is used to generate numerical data or data that can be converted into numbers. Study types that are used in the health and medical field include: Case report or case series - a report on one or more individual patients. There is no "control group" so this study type is considered to have low statistical validity
Introduction. In clinical research, our aim is to design a study, which would be able to derive a valid and meaningful scientific conclusion using appropriate statistical methods that can be translated to the "real world" setting. 1 Before choosing a study design, one must establish aims and objectives of the study, and choose an appropriate target population that is most representative of ...
JOURNAL HOMEPAGE. Research Methods in Medicine & Health Sciences is a peer reviewed journal, publishing rigorous research on established "gold standard" methods and new cutting edge research methods in the health sciences and clinical medicine. View full journal description. This journal is a member of the Committee on Publication Ethics ...
Mixed Methods Research: This type of research combines both quantitative and qualitative research methods to gain a more comprehensive understanding of a phenomenon or problem. ... Research is instrumental in advancing medical knowledge and developing new treatments and therapies. Clinical trials and studies help to identify the effectiveness ...
Job Type: Officer of Administration Regular/Temporary: Regular Hours Per Week: 35 Salary Range: $240,000 - $280,000 The salary of the finalist selected for this role will be set based on a variety of factors, including but not limited to departmental budgets, qualifications, experience, education, licenses, specialty, and training. The above hiring range represents the University's good faith ...
The story so far: The Type 1 Diabetes Grand Challenge, a partnership between the Steve Morgan Foundation, Diabetes UK and JDRF, on Monday, August 12, 2024, announced grants of over £2.7 million ...
Health literacy and health information technology adoption: The potential for a new digital divide. Journal of Medical Internet Research, 18(10), 211-226. McLaughlin, B. K. (2009). Identifying methods to communicate with patients and enhance patient satisfaction to improve return on investment. J Manag Mark Healthc 2009;2(4):427-441.
The data comes as new research found a nearly 19% increase in cases of Type 2 diabetes in the U.S. between 2012 and 2022. Additionally, patients who had a weekly injection of 15 milligrams of the tirzepatide-based drug had an average reduction of 22.9% of their body weight. Those on a placebo lost about 2.1% of their body weight.
Professor Nita Forouhi of the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge, and a senior author on the paper, said: "Our research provides the most comprehensive evidence to date of an association between eating processed meat and unprocessed red meat and a higher future risk of type 2 diabetes.
PLANNING STAGE. The planning stage consists of all the preliminary paperwork and search of the literature done before starting actual research. It includes identifying the problem, reviewing the literature, developing a research question, formulating a hypothesis, determining the type of study, selecting a study design, identifying the target/study population, and seeking informed consent to ...
Among patients undergoing lumbar spinal fusion, the presence of Modic changes is associated with differences in microbial diversity and metabolites in the lumbar cartilaginous endplates (LCEPs ...
Research we reviewed suggests people tend to use more technology at bedtime for two main reasons: ... Red and processed meat consumption associated with higher type 2 diabetes risk, study of 2 ...
Topline. Consuming meat, particularly red and processed meat, and even poultry like chicken and turkey may increase the risk of developing type 2 diabetes in the future, according to a new study ...